Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.


Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
08 2023
Historique:
medline: 17 8 2023
pubmed: 15 8 2023
entrez: 15 8 2023
Statut: ppublish

Résumé

Alcohol septal ablation (ASA) is a minimally invasive treatment for drug-refractory obstructive hypertrophic cardiomyopathy. Detailed assessment of pressure changes and predictors of mortality and procedure success are not well defined. This is a single-center study evaluating pressure changes and predictors of mortality and procedure success in transseptal ASA. Survival analysis and predictors of mortality were assessed using the Kaplan-Meier analysis and Cox regression, respectively. A total of 156 patients were included (mean age, 67.3 years; 46.8% women). Left atrial (LA) pressure and left ventricular outflow tract (LVOT) gradient decreased, whereas aortic pulse pressure (PP) increased post-ASA. Patients with lower baseline mean LA pressure (<median, 19 mm Hg), LVOT gradient reduction >82% (gradient change median), and PP increase >19% (PP change median) had superior survival. On Cox univariable regression, baseline mean LA pressure >median (19 mm Hg; hazard ratio [HR], 2.09 [95% CI, 1.05-4.18]; ASA is associated with an acute decrease in the LVOT gradient and LA pressures and increase in aortic PP. Mean LA pressure, percentage decrease in LVOT gradient, and increase in PP are strong predictors of survival free of all-cause mortality following ASA and are important variables for procedural guidance.

Sections du résumé

BACKGROUND
Alcohol septal ablation (ASA) is a minimally invasive treatment for drug-refractory obstructive hypertrophic cardiomyopathy. Detailed assessment of pressure changes and predictors of mortality and procedure success are not well defined.
METHODS
This is a single-center study evaluating pressure changes and predictors of mortality and procedure success in transseptal ASA. Survival analysis and predictors of mortality were assessed using the Kaplan-Meier analysis and Cox regression, respectively.
RESULTS
A total of 156 patients were included (mean age, 67.3 years; 46.8% women). Left atrial (LA) pressure and left ventricular outflow tract (LVOT) gradient decreased, whereas aortic pulse pressure (PP) increased post-ASA. Patients with lower baseline mean LA pressure (<median, 19 mm Hg), LVOT gradient reduction >82% (gradient change median), and PP increase >19% (PP change median) had superior survival. On Cox univariable regression, baseline mean LA pressure >median (19 mm Hg; hazard ratio [HR], 2.09 [95% CI, 1.05-4.18];
CONCLUSIONS
ASA is associated with an acute decrease in the LVOT gradient and LA pressures and increase in aortic PP. Mean LA pressure, percentage decrease in LVOT gradient, and increase in PP are strong predictors of survival free of all-cause mortality following ASA and are important variables for procedural guidance.

Identifiants

pubmed: 37582173
doi: 10.1161/CIRCINTERVENTIONS.123.013068
pmc: PMC10424819
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e013068

Commentaires et corrections

Type : CommentIn

Références

Heart. 2008 Oct;94(10):1318-22
pubmed: 18450844
Circ Cardiovasc Interv. 2017 Apr;10(4):
pubmed: 28314742
Am J Cardiol. 2011 Feb 15;107(4):600-3
pubmed: 21184995
Clin Res Cardiol. 2007 Dec;96(12):856-63
pubmed: 17891517
Prog Cardiovasc Dis. 1985 Jul-Aug;28(1):1-83
pubmed: 3160067
Pol Merkur Lekarski. 2002 Jul;13(73):25-8
pubmed: 12362500
Am J Hypertens. 2006 Jun;19(6):601-7
pubmed: 16733232
J Am Coll Cardiol. 2018 Dec 18;72(24):3087-3094
pubmed: 30545446
J Thorac Cardiovasc Surg. 2020 Mar;159(3):844-852.e1
pubmed: 31053434
Am J Cardiol. 2008 Feb 15;101(4):516-20
pubmed: 18312769
Heart Lung Circ. 2018 Dec;27(12):1446-1453
pubmed: 29129561
JACC Cardiovasc Interv. 2011 Jun;4(6):704-9
pubmed: 21700258
JACC Cardiovasc Interv. 2008 Oct;1(5):552-60
pubmed: 19463358
J Am Soc Echocardiogr. 2005 Oct;18(10):1074-82
pubmed: 16198885
J Clin Med. 2020 Sep 23;9(10):
pubmed: 32977442
Catheter Cardiovasc Interv. 2017 Nov 1;90(5):861-869
pubmed: 28707362
Catheter Cardiovasc Interv. 2005 Nov;66(3):375-89
pubmed: 16216025
JACC Cardiovasc Interv. 2012 Jun;5(6):675-81
pubmed: 22721664
Clin Cardiol. 2009 Jul;32(7):397-402
pubmed: 19609895
Circulation. 2012 Nov 13;126(20):2374-80
pubmed: 23076968
J Am Coll Cardiol. 2022 May 3;79(17):1647-1655
pubmed: 35483751
Circulation. 2004 Feb 24;109(7):824-7
pubmed: 14967729
Br Heart J. 1993 Jan;69(1):31-5
pubmed: 8457391
Circulation. 2008 Jul 8;118(2):131-9
pubmed: 18591440

Auteurs

Mohamad S Alabdaljabar (MS)

Departments of Internal Medicine (M.S.A.), Mayo Clinic, Rochester, MN.

Emily E Cendrowski (EE)

Cardiovascular Medicine (E.E.C., R.A.N., W.R.M., J.B.G., C.S.R., M.F.E.), Mayo Clinic, Rochester, MN.

Rick A Nishimura (RA)

Cardiovascular Medicine (E.E.C., R.A.N., W.R.M., J.B.G., C.S.R., M.F.E.), Mayo Clinic, Rochester, MN.

William R Miranda (WR)

Cardiovascular Medicine (E.E.C., R.A.N., W.R.M., J.B.G., C.S.R., M.F.E.), Mayo Clinic, Rochester, MN.

Jeffrey B Geske (JB)

Cardiovascular Medicine (E.E.C., R.A.N., W.R.M., J.B.G., C.S.R., M.F.E.), Mayo Clinic, Rochester, MN.

Charanjit S Rihal (CS)

Cardiovascular Medicine (E.E.C., R.A.N., W.R.M., J.B.G., C.S.R., M.F.E.), Mayo Clinic, Rochester, MN.

Mackram F Eleid (MF)

Cardiovascular Medicine (E.E.C., R.A.N., W.R.M., J.B.G., C.S.R., M.F.E.), Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH